B Müllinger

443 total citations
15 papers, 344 citations indexed

About

B Müllinger is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, B Müllinger has authored 15 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in B Müllinger's work include Inhalation and Respiratory Drug Delivery (9 papers), Asthma and respiratory diseases (5 papers) and Neonatal Respiratory Health Research (3 papers). B Müllinger is often cited by papers focused on Inhalation and Respiratory Drug Delivery (9 papers), Asthma and respiratory diseases (5 papers) and Neonatal Respiratory Health Research (3 papers). B Müllinger collaborates with scholars based in Germany, Austria and United States. B Müllinger's co-authors include G. Scheuch, Peter Brand, Thomas Meyer, Konrad Maier, Norbert Weber, M. Mitchard, Rainald Fischer, Rudolf M. Huber, Knut Sommerer and H. Beckmann and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and Pharmacology & Therapeutics.

In The Last Decade

B Müllinger

15 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Müllinger Germany	11	249	95	38	25	22	15	344
Bo Billing Sweden	12	221 0.9×	182 1.9×	44 1.2×	25 1.0×	19 0.9×	22	445
S. Reader United Kingdom	8	220 0.9×	160 1.7×	16 0.4×	10 0.4×	41 1.9×	13	442
Herman-Jan Pennings Netherlands	10	327 1.3×	121 1.3×	63 1.7×	31 1.2×	7 0.3×	12	459
Ahmet Ilgazlı Türkiye	10	186 0.7×	130 1.4×	23 0.6×	59 2.4×	7 0.3×	32	374
M. Guidetti Italy	13	119 0.5×	125 1.3×	47 1.2×	41 1.6×	40 1.8×	31	483
Takashi Mifune Japan	12	152 0.6×	203 2.1×	15 0.4×	8 0.3×	15 0.7×	68	375
Carmelo Giordano Italy	9	85 0.3×	98 1.0×	82 2.2×	16 0.6×	14 0.6×	19	499
Yanling Ding China	10	118 0.5×	102 1.1×	55 1.4×	85 3.4×	25 1.1×	32	479
Marianne Pilet Switzerland	7	216 0.9×	72 0.8×	23 0.6×	53 2.1×	5 0.2×	9	354
Lisa Lane United States	10	45 0.2×	55 0.6×	40 1.1×	20 0.8×	8 0.4×	18	354

Countries citing papers authored by B Müllinger

Since Specialization

Citations

This map shows the geographic impact of B Müllinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Müllinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Müllinger more than expected).

Fields of papers citing papers by B Müllinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Müllinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Müllinger. The network helps show where B Müllinger may publish in the future.

Co-authorship network of co-authors of B Müllinger

This figure shows the co-authorship network connecting the top 25 collaborators of B Müllinger. A scholar is included among the top collaborators of B Müllinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Müllinger. B Müllinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Stein, Markus, Herbert Jamnig, Sabine Scholl‐Bürgi, et al.. (2018). Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study. Therapeutic Advances in Respiratory Disease. 12. 3270513995–3270513995. 20 indexed citations

Gessler, Tobias, Hossein Ardeschir Ghofrani, Matthias Held, et al.. (2017). The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension. Pulmonary Circulation. 7(2). 505–513. 18 indexed citations

Bakker, Elisabeth, Sonia Volpi, B Müllinger, et al.. (2013). Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial. Pediatric Pulmonology. 49(2). 154–161. 8 indexed citations

Bakker, Elisabeth, Sonia Volpi, B Müllinger, et al.. (2010). Efficacy of peripheral deposition of inhaled rhDNase in CF patients during a respiratory tract exacerbation. Journal of Cystic Fibrosis. 9. S62–S62. 6 indexed citations

Martin, Andrew R., Ira Katz, Maximilian Hartmann, et al.. (2010). Laser diffraction characterization of droplet size distributions produced by vibrating mesh nebulization in air and a helium–oxygen mixture. Journal of Aerosol Science. 41(12). 1159–1166. 14 indexed citations

Scheuch, G., Peter Brand, Thomas Meyer, et al.. (2007). Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.. PubMed. 58 Suppl 5(Pt 2). 603–14. 12 indexed citations

Dopfer, R., Peter Brand, B Müllinger, et al.. (2007). Inhalation of tobramycin in patients with cystic fibrosis: comparison of two methods.. PubMed. 58 Suppl 5(Pt 1). 141–54. 16 indexed citations

Brand, Peter, et al.. (2006). 174 Reduction of drug-dose and therapy-costs in the inhalation therapy with high dose tobramycin. Journal of Cystic Fibrosis. 5. S40–S40. 3 indexed citations

Griese, Matthias, Jan Ramakers, Vitaliy Starosta, et al.. (2004). Improvement of Alveolar Glutathione and Lung Function but Not Oxidative State in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 169(7). 822–828. 84 indexed citations

10.

Meyer, Thomas, B Müllinger, Knut Sommerer, et al.. (2003). PULMONARY DEPOSITION OF MONODISPERSE AEROSOLS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Experimental Lung Research. 29(7). 475–484. 11 indexed citations

11.

Brand, Peter, H. Beckmann, Monika Maas Enriquez, et al.. (2003). Peripheral deposition of α₁‐protease inhibitor using commercial inhalation devices. European Respiratory Journal. 22(2). 263–267. 56 indexed citations

12.

Brand, Peter, et al.. (2002). In Vitro Testing of Two Formoterol Dry Powder Inhalers at Different Flow Rates. Journal of Aerosol Medicine. 15(3). 297–303. 39 indexed citations

13.

Betz, Roland, Martin Kohlhäufl, B Müllinger, et al.. (2001). Increased Sputum IL-8 and IL-5 in Asymptomatic Nonspecific Airway Hyperresponsiveness. Lung. 179(2). 119–133. 28 indexed citations

14.

Mitchard, M., et al.. (1987). Ranitidine drug interactions—a literature review. Pharmacology & Therapeutics. 32(3). 293–325. 28 indexed citations

15.

Müllinger, B, et al.. (1985). Responses of human peripheral arteries to agonists: similarities and differences.. PubMed. 44(2). 331–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact